• Nenhum resultado encontrado

Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-- mice

N/A
N/A
Protected

Academic year: 2019

Share "Antibodies against electronegative LDL inhibit atherosclerosis in LDLr-- mice"

Copied!
7
0
0

Texto

Referências

Documentos relacionados

ApoA1: Apolipoprotein A1; CH : Clinical hypercholesterolemia; FH : Familial hypercholesterolemia; HDL : High density lipoprotein; LDL : Low density lipoprotein; LLT:

The higher risk of cardiovascular events has been associated with changes in lipid metabolism through the modification of low-density lipoprotein (LDL) and

Concentrations of se- rum total cholesterol (A) and low- density lipoprotein (LDL) choles- terol (B) according to MDR1 hap- lotype in Brazilian hypercholes- terolemic individuals

Adjusted means for changes (%) in A, total cholesterol (TC); B, high-density lipoprotein cholesterol (HDL-C); C, low-density lipoprotein cholesterol (LDL-C), and D, log of

Regarding the LRP receptor, by comparing pre- chemotherapy values of tumors with those of matched normal breast tissues, the expected pattern of increased expression

LOX-1: oxidized low-density lipoprotein-1 receptor; HUVECs: human umbilical vein endothelial cells; Ox-LDL: oxidative low-density lipoprotein; Poly I: polyinosinic

Lipid profiles including serum FBG, total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-c), very low-density lipoprotein cholesterol (VLDL) and

Fasting blood glucose (FBG), Triglyceride (TG), total cholesterol (TC), low density lipoprotein cholesterol (LDL- C), very low density lipoprotein cholesterol (VLDL-C) and